1109278-84-3
1109278-84-3
Chemical Structure
Zafirlukast-d6
Synonym(s): ICI 204219-d6
- CAS No.: 1109278-84-3
- Formula:C31H27D6N3O6S
- Molecular Weight:581.71
InChIKey: YEEZWCHGZNKEEK-XERRXZQWSA-N
SMILES: O=C(NC1=CC(C(CC2=CC=C(C(NS(=O)(C3=C(C)C=CC=C3)=O)=O)C=C2OC([2H])([2H])[2H])=CN4C([2H])([2H])[2H])=C4C=C1)OC5CCCC5
Biological Activity: Zafirlukast-d6 is deuterated labeled Zafirlukast (HY-17492). Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Zafirlukast-d6 | Zafirlukast-d6 is deuterated labeled Zafirlukast (HY-17492). Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Zafirlukast (Standard) | 99.15% | Zafirlukast (Standard) is the analytical standard of Zafirlukast. This product is intended for research and analytical applications. Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Zafirlukast-13C,d6 | Zafirlukast-13C,d6 is the 13C- and deuterium labeled Zafirlukast. Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Zafirlukast-d7 | Zafirlukast-d7 is the deuterium labeled Zafirlukast. Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Zafirlukast-13C,d3 | Zafirlukast-13C,d3 is the 13C- and deuterium labeled Zafirlukast. Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Zafirlukast | 99.87% | Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
